Search

Nostrum Biodiscovery marks ten years of growth and scientific innovation, celebrating its global presence and a portfolio of technologies designed to accelerate drug discovery.

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events